EDITOR'S PICKS

Read a selection of our subscriber-only news articles

Hand-picked by our editors for you to sample. Use the tags in the right-hand column to filter by regulatory topic or jurisdiction.

RECENT ARTICLES | EDITOR'S PICKS

Amgen/Horizon Therapeutics: FTC Staff Probes Buyer’s Past Drug-Price Increases and Alleged Anticompetitive Tactics 

FTC staff reviewing Amgen’s (AMGN) proposed $27.8 billion acquisition of Horizon Therapeutics (HZNP) is probing the acquirer’s track record of raising drug prices and allegedly shielding its products from competition, sources familiar with the matter said.   The staff is considering whether Amgen’s purchase of Horizon, a developer of treatments for rare autoimmune and severe inflammatory […]

Mar 22, 2023 Read Now >

No articles found in this category